The FDA accepts and grants priority review to BAYRY's sNDA for Kerendia to treat patients with a common form of heart failure.
Bayer said on Monday that it welcomed a new law about to be passed in the U.S. state of Georgia to better protect the maker of crop protection chemicals against glyphosate litigation.
Germany's Bayer has won an injunction to suspend a court ruling that gave Brazilian soybean farmers the right to reimbursement for royalties paid for expired patents of genetically modified soy seeds,
Germany's financial markets watchdog has started an initial probe to examine whether Bayer fairly disclosed plans to get shareholder approval for a potential capital increase, a regulatory source told
Bayer told several brokerages about plans to seek shareholder permission to issue shares one day before formally announcing the news on Friday, which weighed heavily on the stock, analysts' notes seen
Here is how Bayer Aktiengesellschaft (BAYRY) and AbbVie (ABBV) have performed compared to their sector so far this year.
Bayer AG (ETR:BAYN, OTC:BAYZF) has told US lawmakers it may halt sales of its popular Roundup weedkiller in the United States unless stronger legal protections are implemented to protect the company
Bayer said on Friday it would seek shareholder approval to raise fresh equity capital worth close to 35% of its currently outstanding shares over the next three years to be ready for any U.S. litigati
Bayer has warned U.S. lawmakers it could stop selling the popular Roundup weedkiller if they cannot provide better legal protection against product liability litigation, according to a financial analy
BAYRY's fourth-quarter earnings match expectations. Revenues top estimates, driven by the strong performance of its pharmaceutical business.
Bayer Aktiengesellschaft (OTCPK:BAYZF) Q4 2024 Earnings Conference Call March 5, 2025 8:00 AM ET Company Participants Jost Reinhard - IR Bill Anderson - Chairman & CEO Wolfgang Nickl - CFO Rodrigo San
On Wednesday, Bayer AG BAYRY reported fourth-quarter 2024 adjusted EPS of $0.28, missing the consensus of $1.00.
Bayer on Wednesday raised the prospect of a return to earnings growth next year after reiterating that a decline was expected for this year.
Bayer's CEO is facing increasing investor pressure to deliver on turnaround efforts and reverse a forecast earnings decline this year, as the group prepares to release quarterly results on Wednesday.
February is  American Heart Month  - Expert with Bayer Discusses Key Risk Factors for Heart Disease and Shares Practical Tips for Improving Heart Health
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE